Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Safety and Efficacy of Prolonged Levofloxacin Inhalation Solution (1 APT-1026) Treatment for Cystic Fibrosis and Chronic Pseudomonas aeruginosa Airway Infection

Safety and Efficacy of Prolonged Levofloxacin Inhalation Solution (1 APT-1026) Treatment for Cystic Fibrosis and Chronic Pseudomonas aeruginosa Airway Infection

Resource Type

CF Research News

Authors

J. Stuart Elborn
Patrick A. Flume
Fredric Cohen
Jeffery Loutit
Donald R. VanDevanter

References

J Cyst Fibros. 2016 Feb 26. pii: S1569-1993(16)00012-6

Document

PDF icon CF Research News article [1]

Theme

Clinical Trials [2]

Date

Monday, February 1, 2016

Featured resource article

Yes
Source URL:https://www.ecfs.eu/research-article/safety-and-efficacy-prolonged-levofloxacin-inhalation-solution-1-apt-1026-treatment

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-15-00291R2_FINAL_Elborn_16042016.pdf [2] https://www.ecfs.eu/research-article-themes/clinical-trials